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Background: An early and accurate diagnosis of chronic heart failure is a big challenge for a general practitioner.
Assessment of left ventricular function is essential for the diagnosis of heart failure and the prognosis. A gold
standard for identifying left ventricular function is echocardiography. Echocardiography requires input from
specialized care and has a limited access in Swedish primary health care. Impedance cardiography (ICG) is a
noninvasive and low-cost method of examination. The survey technique is simple and ICG measurement can be
performed by a general practitioner. ICG has been suggested for assessment of left ventricular function in patients
with heart failure. We aimed to study the association between hemodynamic parameters measured by ICG and the
value of ejection fraction as a determinant of reduced left ventricular systolic function in echocardiography.
Methods: A non-interventional, observational study conducted in the outpatients heart failure unit. Thirty-six
patients with the diagnosis of chronic heart failure were simultaneously examined by echocardiography and ICG.
Distribution of categorical variables was presented as numbers. Distribution of continuous variables was presented
as a mean and 95% Confidence Interval. Kruskal-Wallis test was used to compare variables and show differences
between the groups. A p-value of <0.05 was considered significant.
Results: We found that three ICG parameters: pre-ejection fraction, left ventricular ejection time and systolic time
ratio were significantly associated with ejection fraction measured by echocardiography.
Conclusions: The association which we found between EF and ICG parameters was not reported in previous
studies. We found no association between EF and ICG parameters which were suggested previously as the
determinants of reduced left ventricular systolic function.
The knowledge concerning explanation of hemodynamic parameters measured by ICG that is available nowadays is
not sufficient to adopt the method in practice and use it to describe left ventricular systolic dysfunction.
Keywords: Heart failure, Reduced left ventricular systolic function, Impedance cardiography, EchocardiographyBackground
Chronic heart failure (HF) is a complex syndrome char-
acterized by a long period of sub-clinical symptoms and
progressive process associated with poor prognosis. The
five-year mortality is six times higher than in general
population [1]. The prevalence of chronic HF in general
population in Sweden is between 2 and 3% and rises
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reproduction in any medium, provided the or10-20% at 70–80 years of age [2,3]. The incidence has
increased mainly due to an increasing proportion of the
elderly in Sweden [4]. It entails one of the highest costs-
of-illness with approximately 2% of the Swedish health
care budget [2,5]. Similar data about prevalence, inci-
dence and costs were reported in other European coun-
tries [6,7] and USA [8].
The majority of patients at risk of chronic HF, e.g. with
coronary heart disease and hypertension, are treated in
primary health care.
An early and accurate diagnosis of HF is a big chal-
lenge for a general practitioner. Assessment of leftl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and the prognosis. The 5-year survival rate correlates
with reduced left ventricular systolic function and de-
creases in patients with HF to 53% compared with 93%
in age- and sex- matched general population [1]. A gold
standard for identifying reduced left ventricular func-
tion is echocardiography [9]. The European Society of
Cardiology considers echocardiography to be manda-
tory for the establishment of HF diagnosis and highly
recommended if HF is suspected [6]. Echocardiography
requires input from specialized care. Its accessibility
is limited in Swedish primary health care and it is
performed only in about 30% of patients with suspected
HF [10,11]. Determination of ejection fraction (EF) by
echocardiography is routinely used for description of left
ventricular systolic function. Potential utility of imped-
ance measurement for assessment of left ventricular
function has been suggested since the 1990s [12] with
clinical application in patients with HF [13,14]. Imped-
ance cardiography (ICG) is a noninvasive and low-cost
method of examination. The survey technique is simple
and ICG measurement can be performed by a general
practitioner. ICG is considered to be reproducible in
ambulatory patients with stable heart failure [15] and
has been suggested as a tool to be used by nurses to de-
tect worsening of left ventricular systolic function in pa-
tients with heart failure [16].
We aimed to study the association between ICG pa-
rameters and the value of EF in echocardiography. If the
association was found, ICG could be a method to evalu-
ate reduced left ventricular function.Figure 1 Electrode placement for impedance
cardiography measurement.Methods
This was a non-interventional, observational study. The
study was conducted in the outpatients heart failure unit
at the Blekinge County Hospital in Karlshamn in
Sweden during the period 6 February 2009 – 6 March
2009. Informed consent was obtained from each partici-
pant. There were 63 patients with the diagnosis of
chronic HF registered at the heart failure unit. All regis-
tered patients were offered participation by a letter send
by a cardiologist. No reminder was send. Heart failure
unit is the secondary care unit. Patients are referred
there from primary care if difficulties with management
of chronic HF occur. Diagnosis of chronic HF was
established before referral. We thought that it was not
necessary to question the diagnosis and we did not
penetrate the way it was made.
Exclusion criteria comprised significant aortic valve in-
sufficiency and severe aortic stenosis, both of which in-
fluence ICG measurement.
The patients were examined by means of echocardiog-
raphy and ICG during one consultation.Both echocardiography and ICG were performed once
in each patient. Echocardiography was performed by an
experienced cardiologist using Vivid 7, GE equipment.
EF was calculated according to modified Simpson’s for-
mula. The following echocardiographic criteria were
used to describe left ventricle systolic function: EF ≥ 50%
normal systolic function,
EF 40–49% mildly impaired systolic function, EF 30-39%
moderately impaired systolic function, EF <30% severely
impaired systolic function. ICG was performed by a gen-
eral practitioner with experience of survey technique using
Niccomo™ monitor (Medis. Medizinische Messtechnik
GmbH,Germany).
Two pairs of dual sensors were placed on the patient’s
neck and two on the sides of the chest (Figure 1). The
skin was prepared in the way similar to the electrocardi-
ography examination. The outer sensors apply a very
low constant and alternating current, imperceptible to
the patient. The inner sensors measure the baseline im-
pedance of the thorax. Impedance changes with each
heartbeat due to changes in the volume and velocity in
the aorta. The changes in impedance are used to
calculate stroke volume, cardiac output and other
hemodynamic parameters. Table 1 contains the list of
ICG parameters measured by Niccomo™.
Table 1 The list of ICG parameters
ICG parameter Unit
Heart rate HR 1/min
Heart period HPD ms
Stroke volume SV ml
Stroke index SI ml/min
Cardiac output CO l/min
Cardiac index CI l/min/m2
Left cardiac work LCW kg · m
Left cardiac work index LCWI kg · m/m2
Velocity index VI 1/1000/s
Accelaration index ACI 1/100/s2
Heather index HI Ohm/s2
Thoracic fluid containce TFC 1/kOhm
Pre-ejection period PEP ms
Left ventricular ejection time LVET ms
Systolic time ratio STR
Ejection time ratio ETR %
Systolic vascular resistance SVR ml/min
Systolic vascular resistance index SVRI ml/min/m2
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ing, in the supine position with the head elevated be-
tween 30–45 degrees for better comfort of the patient.
Data were transferred to an external disc and analysed
thereafter regarding their adequacy.
None of ICG parameters can be directly compared with
EF due to differences in both methods of examinations.
ICG parameters were divided into the following groups:
1. Expression for cardiac work: cardiac output, stroke
volume, left cardiac work.Table 2 Distribution of ICG parameters (value and 95% CI) in
EF ≥50% (n = 13) 40-49% (n = 10)
CI 2.808 (2.56–3.5) 3.14 (2.42–3.53)
SI 42.15 (37.04–47.27) 35.95 (26.96–44.83)
PEP 110.31 (94.38–126,23) 108.4 (95.71–121.1)
LVET 323.08 (285.77–360.38) 292.7 (271.06–314.34)
STR 0.35 (0.29–0.41) 0.38 (0.32–0.43)
ETR 37.15 (34.65–39.66) 37.3 (32.02–42.58)
VI 33.77 (29.28–38.26) 38.4 (29.9–46.9)
ACI 51.84 (42.92–60.77) 64.6 (44.59–84.61)
HI 7.9 (5.81–9.98) 10.03 (6.44–13.61)
LCWI 3.17 (2.7–3.63) 3.95 (2.96–4.93)
SVRI 2452 (2099–2806) 2435 (1899–2971)
TFC 35.12 (2.43–3.17) 33.89 (2.65–3.63)
* p value of <0,05.2. Contractility: velocity index, acceleration index,
Heather index.
3. Fluid status: thoracic fluid content.
4. Expression for systolic function: pre-ejection period,
left ventricular ejection time, systolic time ratio and
ejection time ratio.
5. Expression for the vascular resistance the heart
works against: systolic vascular resistance.
We decided to analyse cardiac output, stroke volume,
left cardiac work and systolic vascular resistance related to
the body surface as cardiac index, stroke index, left cardiac
work index and systolic vascular resistance index.
The study was approved by the research ethics com-
mittee at Lund University.
Statistics
Data were analysed in the STATA version 10 (Stata
Corporation, Texas,USA). Distribution of categorical
variables was presented as numbers. Distribution of con-
tinuous variables was presented as a mean and 95%
Confidence Interval. Kruskal-Wallis test was used to
compare variables and show differences between the
groups. A p-value of <0.05 was considered significant.
Results
We obtained consent for participation from 37 patients
out of 63 patients registered at heart failure unit. Those
37 patients were enrolled into the study. ICG could not
be performed in one patient due to distortions in the
ICG signal and this patient was excluded from further
calculations. The mean age of 36 patients was 68.3 years
(CI 64.2-72.4).
The group comprised 28 men (78%) and 8 women
(22%). The mean age for men was 68.2 (95% CI 64.0 -
72.4) and for women 68.5 (95% CI 54.7-82.3). None ofgroups with different ejection fraction
30-39% (n = 6) <30% (n = 7) p-value
2.6 (2.46–3.29) 2.7 (2.05–2.92) 0.1180
36.86 (28.77–44.94 38.83 (27.46–50.2) 0.2708
139.5 (110.23–168.77) 148 (125.2–170.79) 0.0069*
262 (222.78–301.22) 268.43 (212.7–324.15) 0.0462*
0.54 (0.41–0.66) 0.75 (0.4–0.77) 0.0031*
32.66 (30.04–35.29) 34.57 (32.51–36.63) 0.1934
35.17 (20.42–49.9) 40 (26.12–53.88) 0.61
66 (41.33–90.67) 68.14 (50.3–85.98) 0.26
6.18 (2.98–9.39) 5.8 (2.59–9.0) 0.1006
3.02 (2.5–3.52) 2.87 (2.38–3.35) 0.2624
2662 (2179–3145) 2511 (1743–3279) 0.8549
39.63 (2.17–3.02) 43.99 (2.11–3.28) 0.1461
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severe aortic stenosis. None of the patients reported any
discomfort or adverse reaction associated with ICG
measurement.
Normal left ventricular systolic function was presented
in 13 out of 36 patients (36%), mildly impaired in 9 pa-
tients (25%), moderately and severely impaired each in 7
patients, respectively (19%). Three ICG parameters: pre-
ejection fraction, left ventricular ejection time and sys-
tolic time ratio were associated with EF with significant
p-value.
The results are presented in Table 2.
Discussion
The purpose of this study was to find whether there is
any association between EF measured by echocardiog-
raphy and hemodynamic parameters measured by ICG.
We found associations between EF and three of four
ICG parameters which describe systolic function of the
left ventricle: pre-ejection period, left ventricular ejection
time and systolic time ratio. We did not find any associ-
ation between EF and the fourth parameter which de-
scribes systolic function - ejection time ratio, though it
is directly proportional to left ventricular ejection time.
We cannot explain this. The technique of ICG examin-
ation was correct. Only one examination had insufficient
quality, most likely due to a bad contact between a sen-
sor and the skin. There was no other potential cause of
the distortions in ICG signals. We do not think that the
patients’ condition could influence the quality of ICG
examination and therefore our results. All grades of HF
were represented in our study population. None of the
patients had unstable HF - a condition which can influ-
ence the quality of ICG examination.
A limitation of our study is a small number of patients.
Nevertheless, most of the previous studies concerning
the correlation between ICG and echocardiography had
a small number of participants. This might be a reason
why the results are not ambiguous. Evaluation of left
ventricular function was the subject in previous studies
with ICG but none of the parameters we found associ-
ated with EF was previously regarded as a determinant
of left ventricular systolic dysfunction. Systolic time ra-
tio, however, was able to distinguish preserved from im-
paired EF [17]. Also, a close correlation between systolic
time ratio and changes in EF was observed before and
after treatment in patients with heart failure [18]. An as-
sociation between systolic time ratio and EF was found
in our study.
The following ICG parameters were suggested in an-
other study as determinants of left ventricular systolic
dysfunction: cardiac index, left cardiac work index and
systolic vascular resistance index [19]. We could not
confirm this.The lack of association between cardiac index and EF
found in our study confirms a lack of agreement between
absolute values of cardiac output measured by ICG and by
echocardiography [20]. We did not find any data about
pre-ejection period or left ventricular ejection time as de-
terminants of reduced left ventricular function.
According to the theoretical equation EF is a quotient
of stroke volume and end diastolic volume, cardiac out-
put is a product of stroke volume and heart rate. ICG
was considered to be a reliable method to determine
stroke volume [21]. Owing to these facts, we hypothe-
sized that stroke index and cardiac index would be
determinants of left ventricular systolic function and
would be associated with EF. ICG was a validated
method for measuring cardiac output [22]. Cardiac
output by ICG was significantly correlated with a
thermodilution method as a gold standard even in pa-
tients with heart failure [23,24], which strengthened our
hypothesis.
No association between stroke volume index or car-
diac output index and EF was found in our study.
EF is commonly used to describe cardiac contractility
[25]. We expected to find an association between EF and
ICG parameters which describe contractility: velocity
index, acceleration index and Heather index. Heather
index by ICG has been suggested as the determinant of
reduced left ventricle systolic function [26]. No associ-
ation between EF and those parameters was found in
our study.
Conclusions
The possibility to determine left ventricular function by
ICG makes the method attractive for use in patients with
HF in primary health care. The association which we
found between EF and ICG parameters was not reported
in previous studies.
We found no association between EF and ICG param-
eters which were suggested previously as the determi-
nants of reduced left ventricular systolic function. We
do not think that knowledge concerning explanation of
hemodynamic parameters measured by ICG that is avail-
able nowadays is sufficient to adopt the method in prac-
tice and use it to describe reduced left ventricular
function.
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